Cytodyn Inc (CYDY)

[Everest1]

First post here. I've been following this board since I first invested around a year ago, and want to thank you all for your opinions and educated DD's on CYDY. I'm bullish on PRO-140, but like everyone here, the declining share price is really wearing down on our patience and tolerance. Obviously, in the end, the data will make all this short term action obsolete (good or bad), but the upcoming dilution as these trials still prolong isn't something I look forward to.

I'm just very curious, why is it taking so long to enroll the 30 Adjunct patients (even after the FDA reduction from 300 to 30 which was months ago)? I understand that the requirements for the screening are very strict, but you would assume there would still be at least a few dozen or so that would meet these? If the number of possible patients is so low, how will this data translate to the actual use of combination therapy of PRO-140 in the market where most of the people will not fall under these restrictions? Combination will still be a $1B/year market? If anyone can give a detailed answer, I'd very much appreciate it. Thanks in advance!